phase 2_initiation

Rise Biopharmaceutical Ltd — RP-72 (Phase II Trial Initiation)

April 28, 2026RP-72updated 2mo ago

community read0 votes

Therapy area: Oncology. Indication: Metastatic Pancreatic Cancer, Pancreatic Cancer

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

Data sources

globaldata

Found something off?